Literature DB >> 22895384

Evolution of varicella surveillance--selected states, 2000-2010.

.   

Abstract

Varicella surveillance practices have evolved since varicella first became nationally notifiable in 1972 (1) (Table 1). Because national surveillance data were not adequate for monitoring the impact of varicella vaccine when it became available in the United States, active surveillance for varicella was established in sentinel sites in 1995 (1,2). With declines in varicella incidence after 1 dose of varicella vaccine was added to the routine childhood vaccination schedule in 1996 (3) and a second dose was recommended in 2006 (4), the number of cases of varicella in the active surveillance sites became insufficient to monitor further impact of vaccination. CDC evaluated varicella surveillance data reported via the National Notifiable Diseases Surveillance System (NNDSS) during 2000-2010 to determine whether these data might now be adequate for monitoring vaccination impact. By 2010, a total of 39 states required reporting of varicella cases, 38 states were conducting passive case-based surveillance, and 31 met CDC's ad hoc criteria for adequate and consistent reporting. Varicella incidence in the states that met these criteria declined 79% overall, from 43 per 100,000 population in 2000 to nine in 2010. While 1 dose of varicella vaccine was recommended, incidence declined 43% during 2000-2005, and after a second dose was added to the routine childhood schedule, incidence declined 72% during 2006-2010. State varicella surveillance data reported to CDC through NNDSS are now adequate for monitoring trends in varicella incidence, but continued strengthening of the surveillance system and participation of all states is needed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22895384

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  10 in total

1.  An evaluation of voluntary 2-dose varicella vaccination coverage in New York City public schools.

Authors:  Margaret K Doll; Jennifer B Rosen; Stephanie R Bialek; Hiram Szeto; Christopher M Zimmerman
Journal:  Am J Public Health       Date:  2014-12-18       Impact factor: 9.308

Review 2.  Utilizing health information technology to improve vaccine communication and coverage.

Authors:  Melissa S Stockwell; Alexander G Fiks
Journal:  Hum Vaccin Immunother       Date:  2013-06-04       Impact factor: 3.452

3.  Trends in varicella mortality in the United States: Data from vital statistics and the national surveillance system.

Authors:  Jessica Leung; Stephanie R Bialek; Mona Marin
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

4.  Syndromic Surveillance as a Tool for Case-Based Varicella Reporting in Georgia, 2016-2019.

Authors:  Carolyn M Adam; René Borroto; Ebony Thomas; Jessica Tuttle; Jessica Pavlick; Cherie L Drenzek
Journal:  Public Health Rep       Date:  2021-10-13       Impact factor: 3.117

5.  Varicella Vaccine Effectiveness in Preventing Community Transmission in the 2-Dose Era.

Authors:  Dana Perella; Chengbin Wang; Rachel Civen; Kendra Viner; Karen Kuguru; Irini Daskalaki; D Scott Schmid; Adriana S Lopez; Hung Fu Tseng; E Claire Newbern; Laurene Mascola; Stephanie R Bialek
Journal:  Pediatrics       Date:  2016-03-14       Impact factor: 7.124

Review 6.  Varicella Zoster Virus: A Common Cause of Stroke in Children and Adults.

Authors:  Catherine Amlie-Lefond; Don Gilden
Journal:  J Stroke Cerebrovasc Dis       Date:  2016-04-29       Impact factor: 2.136

7.  Impact of a routine two-dose varicella vaccination program on varicella epidemiology.

Authors:  Stephanie R Bialek; Dana Perella; John Zhang; Laurene Mascola; Kendra Viner; Christina Jackson; Adriana S Lopez; Barbara Watson; Rachel Civen
Journal:  Pediatrics       Date:  2013-10-07       Impact factor: 7.124

8.  Two-dose varicella vaccine effectiveness and rash severity in outbreaks of varicella among public school students.

Authors:  Carrie A Thomas; Thein Shwe; Dee Bixler; Maria del Rosario; Scott Grytdal; Chengbin Wang; Loretta E Haddy; Stephanie R Bialek
Journal:  Pediatr Infect Dis J       Date:  2014-11       Impact factor: 2.129

Review 9.  Zeroing in on zoster: A tale of many disorders produced by one virus.

Authors:  Kristin M Galetta; Don Gilden
Journal:  J Neurol Sci       Date:  2015-10-03       Impact factor: 3.181

10.  Assessment of varicella surveillance and outbreak control practices - United States, 2012.

Authors:  Adriana S Lopez; Meredith Lichtenstein; Scott D Schmid; Stephanie Bialek
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-09-12       Impact factor: 17.586

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.